Page 1669 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1669

Chapter 91  Pain Management and Antiemetic Therapy in Hematologic Disorders  1487


            62.  Niscola P, et al: Pain syndromes in the setting of haematopoietic stem   69.  Gloth FM, 3rd.: Pharmacological management of persistent pain in older
               cell  transplantation  for  haematological  malignancies.  Bone  Marrow   persons: focus on opioids and nonopioids. J Pain 12:S14, 2011.
               Transplant 41:757–764, 2008.                       70.  Moore RA, Straube S, Wiffen PJ, et al: Pregabalin for acute and chronic
            63.  Walters MC, et al: Impact of bone marrow transplantation for symp-  pain in adults. Cochrane Database Syst Rev (3):CD007076, 2009.
               tomatic  sickle  cell  disease:  an  interim  report.  Blood  95:1918–1924,   71.  Basch E, Prestrud AA, Hesketh PJ, et al: Antiemetics: American society
               2000.                                                 of  clinical  oncology  clinical  practice  guideline  update.  J  Clin  Oncol
            64.  Walters  MC,  et al:  Pulmonary,  gonadal,  and  central  nervous  system   29:4189–4198, 2011.
               status after bone marrow transplantation for sickle cell disease. Biol Blood   72.  National Comprehensive Cancer Network: Clinical practice guidelines in
               Marrow Transplant 16(2):263–272, 2010.                oncology: Antiemesis, v.1.2015. Available at <www.ncc.org/professionals/
            65.  Hsieh  MM,  et al:  Nonmyeloablative  HLA-matched  sibling  allogeneic   physician_gls/pdf/antiemesis.pdf>. (Accessed April 15.04.15.).
               hematopoietic stem cell transplantation for severe sickle cell phenotype.   73.  Gralla RJ, Bosnjak SM, Hontsa A, et al: A phase III study evaluating the
               JAMA 312(1):48–56, 2014.                              safety and efficacy of NEPA, a fixed-dose combination of netupitant and
            66.  Hershman D, Lacchetti C, Dworkin RH, et al: Prevention and manage-  palonosetron, for prevention of chemotherapy-induced nausea and vom-
               ment  of  chemotherapy-induced  peripheral  neuropathy  in  survivors  of   iting over repeated cycles of chemotherapy. Ann Oncol 25:1333–1339,
               adult cancers: American society of clinical oncology practice guideline. J   2014.
               Clin Oncol 32:1941–1967, 2014.                     74.  Hocking CM: Kichenadasse G. Olanzapine for chemotherapy-induced
            67.  Lavoie Smith EM, Pang H, Cirrincione C, et al: Effect of duloxetine on   nausea  and  vomiting:  a  systematic  review.  Support  Care  Cancer
               pain, function, and quality of life among patients with chemotherapy-  22(4):1143–1151, 2014.
               induced  painful  peripheral  neuropathy:  a  randomized  clinical  trial.   75.  Machado  Rocha  FC,  et al:  Therapeutic  use  of  Cannabis  sativa  on
               JAMA 309(13):1359–1367, 2013.                         chemotherapy-induced  nausea  and  vomiting  among  cancer  patients:
            68.  Culberson JW, Ziska M: Prescription drug misuse/abuse in the elderly.   systematic review and meta-analysis. Eur J Cancer Care (Engl) 17(5):431–
               Geriatrics 63:22, 2008.                               443, 2008.
   1664   1665   1666   1667   1668   1669   1670   1671   1672   1673   1674